Advanced Search

Study Preview



Study Title and Description

Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine.



Key Questions Addressed
7 Key Question 7. What is the effectiveness of currently recommended antiviral treatments in achieving a SVR in patients with HCV infection?
  • Comments Comments (
    0
    ) |
8 Key Question 8. What are the harms of currently recommended antiviral treatments?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine.
Author Lalezari J., Sullivan JG., Varunok P., Galen E., Kowdley KV., Rustgi V., Aguilar H., Felizarta F., McGovern B., King M., Polepally AR., Cohen DE.
Country Quest Clinical Research, San Francisco, CA, United States. Electronic address: drjay@questclinical.com.
Year 2015
Numbers Pubmed ID: 25839406

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-9


Results & Comparisons

No Results found.